XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
DNA Ginkgo Bioworks
- 14.730
- +1.180+8.71%
Close Feb 14 16:00 ET
- 14.690
- -0.040-0.27%
Post 20:01 ET
846.66MMarket Cap-1.14P/E (TTM)
15.330High13.920Low2.87MVolume14.000Open13.550Pre Close42.39MTurnover7.22%Turnover RatioLossP/E (Static)57.48MShares64.40052wk High1.06P/B585.96MFloat Cap5.26052wk Low--Dividend TTM39.78MShs Float634.560Historical High--Div YieldTTM10.41%Amplitude5.260Historical Low14.753Avg Price1Lot Size
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!
Ginkgo Bioworks Stock Forum
geekwire.com/20...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...
No comment yet